Skip to content

Comparison of two machines that help babies with breathing difficulties

Comparison of CPAP Machines With Reusable vs Disposable Circuits - CPAP study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/05/008581
Enrollment
80
Registered
2017-05-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J00-J99- Diseases of the respiratory system Health Condition 2: null- Newborn infants with neonatal respiratory distress syndrome

Interventions

Intervention1: Dolphin CPAP: CPAP machine with oxygen intake and an on-board air compressor, and integrated blender and humidifier, delivering heated humidified blended gases through a Fisher-Paykel n

Sponsors

Medical Technology Transfer and Services Hong Kong
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: IN-1 Infants born at the hospital (â??inborn infantsâ??) IN-2 Infants with a gestational age at birth (weeks +days) in the range >= 28+0 to IN-3 Infants thought to have RDS (clinically diagnosed after onset of respiratory distress IN-4 Infants <24 hours old at the time of fulfilling other inclusion criteria.

Exclusion criteria

Exclusion criteria: EX-1 Infants with a 1-minute Apgar score EX-2 Infants who received MV prior to randomisation; EX-3 Infants with suspected meconium aspiration syndrome will be excluded to avoid any imbalance in this condition across groups; EX-4 Infants clinically suspected to have another specified serious condition as their main disease process, diagnosed prior to randomisation, specifically: cardiac anomaly, other congenital malformation with respiratory sequelae, septicaemia, pulmonary haemorrhage, pneumothorax, meningitis, poor respiratory effort or recurrent apnoea, or brain haemorrhage (IVH Grades III or IV); EX-5 Infants who have an airway abnormality precluding the use of the standard CPAP interface proposed for this study (e.g., Pierre-Robin sequence, cleft lip or cleft palate) or who have a neuromuscular condition that interferes with respiration; EX-6 Infants whose treating clinician believes should not be randomised due to some other condition, or for any other reason (reason to be documented).

Design outcomes

Primary

MeasureTime frame
Fraction of inspired oxygen (FiO2), measured as a change from baselineTimepoint: 6, 12, 24, 48 and 72 hours after treatment commencement

Secondary

MeasureTime frame
A Serious adverse Event (SAEs) is any untoward medial occurrence that: Results in death; Is life-threatening (see definitional note in ClinicalTrials.gov registration); Requires inpatient hospitalisation or prolongation of existing hospitalisation; Results in persistent or significant disability/incapacity; or Is a congenital anomaly/birth defectTimepoint: From date and time of birth to date and time of hospital discharge, assessed to a maximum of 2 months of age.;Arterial blood gas analyses (pH, PaO2, PaCO2), measured as a change from baseline (where measured)Timepoint: 6, 12, 24, 48 and 72 hours after treatment commencement (where available);CPAP failure or surfactant provision (i.e., Secondary Outcomes 4 or 5)Timepoint: From date and time of randomization to date and time of cessation of CPAP treatment, or until date and time of hospital discharge, if infant is on CPAP treatment until discharged (i.e., dies or is transferred), assessed to a maximum of 2 months of age.;CPAP failure: Death or need for intubation and mechanical ventilation as demonstrated by an FiO2 requirement â?¥ 60% for â?¥ 1 hour to maintain SpO2 at 90-95%Timepoint: From date and time of randomization to date and time of cessation of CPAP treatment, or until date and time of hospital discharge, if infant is on CPAP treatment until discharged (i.e., dies or is transferred), assessed to a maximum of 2 months of age;Duration of CPAP treatment (hours) in infants that do not fail CPAPTimepoint: From date and time of randomization to date and time of cessation of CPAP treatment, or until date and time of hospital discharge, if infant is on CPAP treatment until discharged (i.e., dies or is transferred), assessed to a maximum of 2 months of age.;Oxygen saturation by pulse oximetry (SpO2), measured as a change from baselineTimepoint: 6, 12, 24, 48 and 72 hours after treatment commencement;Respiratory rate (breaths/minute), measured as a change from baselineTimepoint: 6, 12, 24, 48 and 72 hours after tr

Countries

India

Contacts

Public ContactDr Pradeep GCM

Ramaiah Medical College

P_gcm@yahoo.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026